Abstract
Using the well-established DMH model for colon neoplasia, we demonstrated that a high-fiber diet pair-fed to animals was associated both with certain changes in bacterial profile and with protection against experimental colon neoplasia. The addition of metronidazole on a long-term basis to both hig-hand low-fiber diets did not alter stool bacteroides counts as expected and was associated with an apparent cocarcinogenic effect. Concern exists among surgeons and gastroenterologists as to whether metronidazole places their patients at risk. The status of long-term metronidazole therapy for patients with Crohn's disease is a pertinent example. In view of our findings, it is important to further elucidate the metabolism of metronidazole in both the rat and human gut.
| Original language | English |
|---|---|
| Pages (from-to) | 66-70 |
| Number of pages | 5 |
| Journal | American Journal of Surgery |
| Volume | 145 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1983 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Surgery
Fingerprint
Dive into the research topics of 'Increased incidence of experimental colon cancer associated with long-term metronidazole therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver